A Study Evaluating the Efficacy and Safety of Multiple Therapies in Cohorts of Participants With Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Durvalumab
Related studies linked through entity extraction aliases.
Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial
- Status
- WITHDRAWN
- Phase
- PHASE2
Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1
A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Papaverine in Combination With Chemoradiation for the Treatment of Stage II-III Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Chemo-immunotherapy, Hypo-fractionated RT and Maintenance Immunotherapy for Stage III NSCLC.
- Status
- RECRUITING
- Phase
- PHASE2
Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Concomitant Radiotherapy, Tremelimumab & Durvalumab for Advanced NSCLC Patients Progressing on First-line Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
To Evaluate the Efficacy of Durvalumab + Anlotinib in Terms of OS and PFS.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2